RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
RainBIO has raised $250K in total funding. The most recent round was Debt Financing. The last funding was announced in July 2021.
RainBIO's investors include North Carolina Biotechnology Center.
RainBIO is headquartered in Raleigh, United States.
RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
RainBIO is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RainBIO — Funding & Investors." VCBacked, July 30, 2021, https://www.vcbacked.co/company/rainbio. Accessed November 17, 2026.
VCBacked. (2021). RainBIO — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/rainbio
{{cite web |title=RainBIO — Funding & Investors |url=https://www.vcbacked.co/company/rainbio |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at RainBIO? Request a listing update